Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMAZE4: Once-weekly NNC0487-0111 in overweight/obesity with obstructive sleep apnoea on PAP
jRCT2031260073Recruiting
- Sponsor
- Polaris IRB
- Start
- May 2026
- Modality
- Small Molecules, Peptides
01
Overview
Randomised, double-blind trial in obesity, Overweight and obstructive sleep apnea hypopnea syndrome (OSAHS) comparing NNC0487-0111 arm with Placebo arm (2 arms). Primary endpoints: Relative change in body weight and Change in apnoea-hypopnoea index. Started May 2026; status: recruiting.
02
Drugs
amycretin
03
Conditions
obesityOverweightobstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on jRCT2031260073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031260073.